Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa
dc.article.end-page | 1320 | en |
dc.article.start-page | 1314 | en |
dc.citation.doi | 10.1007/S10461-022-03867-3 | en |
dc.contributor.author | Fatima Laher | en |
dc.contributor.author | Kennedy Otwombe | en |
dc.contributor.author | Ofentse Mokwena | en |
dc.contributor.author | L G Bekker | en |
dc.contributor.author | M Allen | en |
dc.date.accessioned | 2024-07-23T05:54:27Z | |
dc.date.available | 2024-07-23T05:54:27Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 1090-7165 | en |
dc.identifier.uri | https://hdl.handle.net/10539/39052 | |
dc.journal.title | Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa | en |
dc.journal.volume | 27 | en |
dc.publisher | SPRINGER/PLENUM PUBLISHERS | en |
dc.title | Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 310.23 KB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client